Studies have shown that in both male and female CRC cell lines, treatment with E2 alone or in combination with progesterone or 5-FU inhibits ERα expression while upregulating ERβ expression, promoting cell cycle arrest and apoptosis [62–64]. Here, ESR2 is linked to colorectal carcinoma.